Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Aug;326(2):363-8.
doi: 10.1124/jpet.108.139543. Epub 2008 May 7.

Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite

Affiliations

Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite

Jie Liu et al. J Pharmacol Exp Ther. 2008 Aug.

Abstract

Mineral arsenicals have long been used in traditional medicines for various diseases, yet arsenic can be highly toxic and carcinogenic. Arsenic in traditional medicines typically comes from deliberate addition for therapeutic purposes, mainly in the form of mineral arsenicals, including orpiment (As2S3), realgar (As4S4), and arsenolite (contains arsenic trioxide, As2O3). Inorganic arsenic is now accepted in Western medicine as a first line chemotherapeutic agent against certain hematopoietic cancers. This perspective analyzes the pharmacology and toxicology of these arsenicals used in traditional medicines. Orpiment and realgar are less soluble and poorly absorbed from the gastrointestinal tract, whereas the bioavailability of arsenic trioxide is similar to inorganic arsenic salts such as sodium arsenite. Pharmacological studies show that arsenic trioxide and realgar are effective against certain malignancies. Orpiment and realgar are used externally for various skin diseases. Realgar is frequently included as an ingredient in oral traditional remedies for its antipyretic, anti-inflammatory, antiulcer, anti-convulsive, and anti-schistosomiasis actions, but the pharmacological basis for this inclusion still remains to be fully justified. Toxicological studies show that cardiovascular toxicity is the major concern for arsenic trioxide and that the gastrointestinal and dermal adverse effects may occur after prolonged use of mineral arsenicals. Little is known regarding the possible secondary cancers resulting from the long-term use of any of these arsenicals. Similar to the safety evaluation of seafood arsenicals, total arsenic content alone appears to be insufficient for mineral arsenical safety evaluation. Arsenic speciation, bioavailability, and toxicity/benefit should be considered in evaluation of mineral arsenical-containing traditional medicines.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Acute oral toxicity (LD50) of arsenicals in rodents. A: common inorganic arsenicals and their organic arsenical metabolites; B: arsenic species in seafood; C: mineral arsenicals. N/A: LD50 data is not available

References

    1. ATSDR . Toxicological Profile for Arsenic (update) Agency for Toxic Substances and Disease Registry; Atlanta, Georgia: 2005. - PubMed
    1. Borak J, Hosgood HD. Seafood arsenic: implications for human risk assessment. Regul Toxicol Pharmacol. 2007;47:204–412. - PubMed
    1. Carter DE, Aposhian HV, Gandolfi AJ. The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review. Toxicol Appl Pharmacol. 2003;193:309–334. - PubMed
    1. Chen SY, Li XM, Liu SX. A review of the research on malignant hemopathies treated with arsenic-containing Chinese drugs. Zhongguo Zhong Yao Za Zhi. 2000;25:454–7. 473. - PubMed
    1. Chou WC, Dang CV. Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies. Curr Opin Hematol. 2005;12:1–6. - PubMed

Publication types

LinkOut - more resources